Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You are browsing as a GUEST
Title of the item:

Phase IV Study of Sunitinib in Chinese Patients with Imatinib-Resistant or Imatinib-Intolerant Gastrointestinal Stromal Tumors

Title :
Phase IV Study of Sunitinib in Chinese Patients with Imatinib-Resistant or Imatinib-Intolerant Gastrointestinal Stromal Tumors
Authors :
Shen, Lin
Sun, Yan
Xu, Jian-Ming
Linn, Carlos
Wang, Qiao
Yang, Li-Qiang
Qin, Shu-Kui
Show more
Subject Terms :
Medicine
Cancer
Publisher :
Figshare, 2018.
Publication Year :
2018
Collection :
Datacite
DOI :
10.6084/m9.figshare.5918770.v1
Accession Number :
edsair.dedup.wf.001..01a9f59a57c6f211121e79ec8a2a706a
Article full text The full text of this article can be found here. https://link.springer.com/article/10.1007/s40487-017-0052-4 Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please contact adisrapidplus@springer.com. The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content. Other enhanced features include, but are not limited to: • Slide decks • Videos and animations • Audio abstracts • Audio slides

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.